Razobet-20 Injection (Rabeprazole Injection IP) – For IV Use Only

Razobet-20 Injection contains Rabeprazole Sodium IP, a potent proton pump inhibitor (PPI) formulated for intravenous administration. It is primarily used for managing acid-related disorders, including gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and peptic ulcers in patients unable to take oral medication.

Indications & Uses:

• Gastroesophageal Reflux Disease (GERD):
  • • Rapid acid suppression for severe reflux and heartburn relief.
• Peptic & Duodenal Ulcers:
  • • Promotes faster ulcer healing and reduces acid secretion.
• Zollinger-Ellison Syndrome:
  • • Effectively controls excessive stomach acid production.
• Prevention of Stress-Induced Ulcers in Critically Ill Patients:
  • • Ideal for hospitalized patients needing IV acid control therapy.

Dosage & Administration:

• • Administered intravenously (IV) under medical supervision.
• • Dosage varies based on patient condition and severity.
• • Should be reconstituted and given as a slow IV infusion.

Possible Side Effects:

• • Common: Headache, dizziness, nausea, mild diarrhea.
• • Rare (Seek medical help): Allergic reactions, abnormal liver function, severe stomach pain.

Precautions & Warnings:

• • Use cautiously in patients with liver impairment.
• • May interact with antifungal agents, anticoagulants, and antibiotics.
• • Not recommended during pregnancy or breastfeeding unless advised by a doctor.

Category:

IV Proton Pump Inhibitors (PPIs) | Gastrointestinal Care